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Abstract
Endoscopic ultrasonography (EUS) is the most efﬁcient diagnostic method for local staging of gastric cancer, being able to
differentiate between early and advanced primary gastric tumors with high performance rates. Although the accuracy of EUS
for node (N) staging is lower than for the tumor (T) stage, ultrasound elastography could be used as a complementary
method for the characterization and differentiation of benign and malignant lymph nodes in real time. EUS-guided ﬁne-
needle aspiration is indicated in gastric cancer if the positive result has a special impact on the clinical management of the
patient. This article is part of an expert video encyclopedia.
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Materials
• Endosonography: Ultrasound system EUB 8500; Hitachi
Medical System, Japan.
• Linear endoscopic ultrasound (EUS): Pentax EG 3830UT;
Pentax, Tokyo, Japan.
Background and Endoscopic Procedure
Correct assessment of tumor, node and metastasis (TNM)
stage is essential for the management of patients with gastric
cancer. Patient prognosis and therapeutic decisions depend on
tumor extension of the gastric wall and the presence of local
lymph node metastasis, becoming more important as non-
surgical treatment regimens have improved.
EUS is the most efﬁcient diagnostic method for staging of
gastric cancer locally, and it has clearly managed to change the
therapeutic decision in a substantial number of patients.1 In a
recent meta-analysis of the literature, EUS had 86% sensitivity
and 91% speciﬁcity for T staging, though it is nevertheless
lower for N staging.2 Furthermore, it is able to differentiate
between early to intermediate (T1–2) and advanced (T3–4)
primary gastric tumors with high performance rates.
There are two scanning methods for the examination
of the stomach: the water-ﬁlling method (by introducing
300–500 ml of 0.9% isotonic saline solution into the stom-
ach) and the balloon contact method. Filling the stomach
with liquid allows a good deﬁnition of the gastric wall struc-
ture, but it is difﬁcult to examine the cardia and prepyloric
areas, where the water-ﬁlled balloon method is more helpful.
However, most of the authors prefer to work without ﬁlling
the stomach with liquid. It is important to keep the transducer
tip perpendicular to the lesion in order to obtain a clear image.
The gastric wall is visualized by EUS with 7.5–12-MHz trans-
ducers as a ﬁve-layered structure. From the digestive tract
lumen inward, the ﬁrst hyperechoic and the second hypoe-
choic layers correspond to the mucosa, the third hyperechoic
layer to the submucosa, the fourth hypoechoic layer to the
muscularis propria, and the ﬁfth hyperechoic layer to the
subserosa and serosa. Cancer of the stomach is usually imaged
as a hypoechoic disruption of the wall layers. In the seventh
edition of the AJCC Cancer Staging Manual,3 the tumor mass is
classiﬁed as follows: T is carcinoma in situ (intraepithelial
without invasion of the lamina propria). T1 is subdivided: T1a
tumor invades lamina propria or muscularis mucosae and T1b
tumor invades submucosa. T2 tumor invades muscularis
propria. T3 tumor penetrates subserosal connective tissue
without invasion of visceral peritoneum or adjacent structures.
T4 is subdivided: T4a tumor invades serosa and T4b tumor
invades adjacent structures. Tumors arising at the esophago-
gastric junction, or in the stomach 5 cm or less from the
junction and crossing the esophagogastric junction, are staged
using the TNM system for esophageal carcinoma.
Locoregional staging of gastric tumors by EUS might be
incorrect because of overstaging, which is more frequently
encountered than understaging. This is due, most likely, to
misinterpretation of peritumoral inﬂammatory reaction,
presence of necrosis or peritumoral ﬁbrosis (especially in ul-
cerative forms and small tumors), or tangential view of the
gastric wall. Given the new TNM classiﬁcation according to the
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seventh edition of the AJCC Cancer Staging Manual,3 it will be
even more difﬁcult in the future to distinguish stage T2 tumors
(muscularis propria invasion) from T3 tumors (subserosal
invasion), respectively, from T4a tumors (inﬁltrating the ser-
osa). Understaging usually occurs when there are micro-
metastases in the deep layers of the gastric wall or focal
invasion of certain layers, which cannot be detected by EUS.
New techniques of image enhancement in EUS, using
microbubble ultrasound contrast agents, could lead to better
characterization of tumor vascularity, as well as differentiation
of tumor stages or detection of resectability, through better
visualization of vascular structures. In the authors’ experience,
gastric cancer shows signiﬁcant enhancement after intravenous
injection of a second-generation contrast agent (SonoVue;
Bracco Diagnostics, Inc, Bracco, Italy), with signiﬁcant intratu-
moral arterial type vascular signals. The role of contrast-en-
hanced EUS in gastric cancer is not clearly established yet, but
the correlation between intratumoral microvessel density, dif-
ferent angiogenic factors (including vascular endothelial growth
factor), and the microvascularity of tumors has been demon-
strated. This could allow early monitoring of the efﬁcacy of
antiangiogenic agents based on tumor perfusion quantiﬁcation,
before morphological changes become apparent and prognosis
assessment of patients.4,5 Likewise, EUS elastography has been
suggested for characterization of tumors or enhanced detection
of tumor stages. Furthermore, both techniques might be more
important during follow-up in locally advanced or metastatic
gastric cancer patients who are not referred to surgery but
undergo chemotherapy and/or antiangiogenic treatment.
Differentiation of benign from the malignant lymph nodes
is often difﬁcult because of the low accuracy of EUS imaging
criteria of malignancy, and limited penetration of the ultra-
sound beam. The authors consider metastatic a lymph node
that fulﬁlls at least three of the following four criteria: size over
1 cm, round in shape, with well-deﬁned margins, and
hypoechogenicity. Ultrasound elastography could be used as a
complementary method for the characterization and differ-
entiation of benign and malignant lymph nodes in real time;
recent studies reporting sensitivity, speciﬁcity, and high ac-
curacy (91.7%, 94.4%, and 92.86%).6 This is especially im-
portant for peritumoral lymph nodes where EUS ﬁne-needle
aspiration (FNA) cannot be performed because the needle
would pass through tumor tissue.
To differentiate malignant nodes, EUS-guided FNA (EUS-
FNA) can be used with very good speciﬁcity, although it is not
routinely indicated in gastric cancer, unless the positive result
has a special impact on the clinical management of the patient
(e.g., presence of mediastinal adenopathies).7 EUS-FNA can
conﬁrm the presence of distant metastases located in the
mediastinum, but also in the liver (left lobe), para-aortic,
portal, and celiac lymph nodes, omentum, adrenal glands,
and neoplasic ascites.
Key Learning Points/Tips and Tricks
• EUS is the most efﬁcient diagnostic method for local sta-
ging of gastric cancer, for both T and N stages.
• Locoregional staging by EUS might be incorrect because of
understaging due to micrometastases present in the deeper
layers of the digestive tract or lymph nodes, respectively,
overstaging due to the presence of peritumoral ﬁbrosis and
inﬂammation (especially in stages T1 and T2, and/or ul-
cerative types), or large reactive lymph nodes.
• EUS-FNA is not routinely indicated in gastric cancer, unless
it can conﬁrm the presence of distant metastases.
Scripted Voiceover
Time (min:sec) Voiceover text
00:00 We present an adenocarcinoma of the cardia
evaluated by endosonography for
locoregional staging. Endoscopic
ultrasound examination reveals a large
gastric tumor, hypoechogenic and
heterogeneous, inﬁltrating the gastric wall
including serosa and penetrating the pleura.
Because the tumor invades the
esophagogastric junction and extends into
the esophagus, treatment will be staged
according to the principles of esophageal
cancer, pleural invasion corresponding to
stage T4a as per AJCC 7th edition.
Gray-scale endoscopic
ultrasound
00:30 Vascularity was assessed by power Doppler
endoscopic ultrasound, which shows
discrete Doppler signals inside the tumoral
mass. After injection of 2.4 mL of a second-
generation contrast agent (SonoVue) and
disappearance of blooming artifacts, we
observe emphasis of the Doppler signals,
which are of the arterial type in pulsed
Doppler mode.
Color
Dopplerþ contrast-
enhancement
1:15 During real-time elastography, the tumor
appears as an inhomogeneous hard area,
being colored mostly in blue (hard) on the
left panel. Endoscopic ultrasound
examination also revealed the presence of a
single lymph node that meets the criteria
for malignancy: more than 1 cm in
diameter, hypoechogenic, round in shape,
with well-deﬁned margins. Endoscopic
ultrasound elastography mode highlights
the lymph node as an inhomogeneous hard
area (mixed green-cyan-blue) on the left
panel.
Real-time elastography
2:00 There was no evidence of ascites, mediastinal
adenopathy or metastasis of the left liver
lobe or left adrenal.
Other ﬁndings
2:15 In conclusion, based on the endoscopic
ultrasound evaluation, it was established
that the tumor has a locally advanced
disease, stage T4aN1Mx.
Conclusion
3:00 For comparison, we present another case of
gastric carcinoma stage T2. A gastric tumor
that appears hypoechoic and
heterogeneous can be seen inﬁltrating the
gastric wall through the fourth
hypoechogenic layer, which corresponds to
muscularis propria.
Another example
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